Tourmaline Bio Inc 's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Tourmaline Bio Inc 's ROA in the second quarter of 2025?
Tourmaline Bio Inc recorded a cumulative net loss of $-88 million during 12 months ending in the second quarter of 2025, resulting in a negative return on assets (ROA) of -29.58%.

However, within the Healthcare sector 450 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2025 from 3769 to 3778.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Total Assets Change	-21.95 %	-20.09 %	47.66 %	103.25 %	51.44 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-88	-83	-73	-49	-34
Return On Assets (TTM)	-29.58 %	-26.06 %	-21.78 %	-15.71 %	-12.73 %
TRML's Total Ranking	# 3778	# 3769	# 4251	# 3583	# 3524
Total Assets (TTM) in million	269	287	311	329	345
Seq. Total Assets Change	-6.22 %	-7.51 %	-5.7 %	-4.57 %	-3.99 %
Seq. Net Income Change	-	-	-	-	-

TRML's 5 Years Annual ROA >> Back to TRML Management Effectiveness >> Compare TRML ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 52
Sector	# 451
Overall	# 3726

Return On Assets Statistics
High	Average	Low
-12.86 %	-27 %	-44.7 %
(Jun 30 2024)		(Jun 30 2023)

Financial Statements
Tourmaline Bio Inc 's Assets	$ 269 million	TRML's Balance sheet
Tourmaline Bio Inc 's Income	$ -23 million	Quarterly TRML's Income Statement
TRML's Income by Division		See TRML's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	FY
Y / Y Total Assets Change	47.66 %	9.55 %	-23.65 %	-	-
Total Assets in million	311	210	192	251	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-73	-42	-74	-48	0
Annual Return On Assets	-23.58 %	-20.03 %	-38.49 %	-19.02 %	-

TRML's 5 Years Annual ROA >> Back to TRML Management Effectiveness >> Compare TRML ROA to its Competitors

More Return On Assets Ratios
TRML's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TRML's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TRML's Competitors
Subscribers only: Roa for Tourmaline Bio Inc 's Suppliers
Subscribers only: Return On Assets for TRML's Customers

You may also want to know
TRML's Roi	TRML's Inventory Turnover Ratio	TRML's Growth Rates	TRML's Dividend Comparisons
	TRML's Profitability Ratios	TRML's Asset Turnover Ratio	TRML's Dividend Growth
TRML's Roe	TRML's Valuation Ratios	TRML's Financial Strength Ratios	TRML's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector

ROA

Date modified: 2026-09-08T22:38:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.